We found increased serum levels of the Th17-related cytokines IL-8, IL-21, IL-22, the inflammatory cytokines GRO-α MIP-1β, IP10 and APRIL in patients with AQP4+ NMOSD compared to MS. This evidence concerns the gene IL22 and myeloid sarcoma.